Prosensa To Present Corporate Overview At The 32nd Annual J.P. Morgan Healthcare Conference

Leiden, The Netherlands, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) announcedtoday that Hans GCP Schikan, Chief Executive Officer, will presenta corporate overview at the 32 nd Annual J.P. MorganHealthcare Conference on Thursday, January 16 at 10:00AM PacificTime at the Westin St. Francis Hotel in San Francisco. A livewebcast of the presentation can be accessed through the Investors& Media section of the Prosensa corporate website at http://ir.prosensa.eu/events.cfmand will be archived for 90 days.

About Prosensa Holding N.V.

Prosensa (NASDAQ: RNA) is a Dutch biotechnologycompany engaged in the discovery and development of RNA-modulatingtherapeutics for the treatment of genetic disorders. Its primaryfocus is on rare neuromuscular and neurodegenerative disorders witha large unmet medical need, including Duchenne muscular dystrophy,myotonic dystrophy and Huntington's disease.

www.prosensa.com
CONTACT: Celia Economides	         Senior Director, IR & Corporate Communications         Phone: +1 917 975 1983         Email: c.economides@prosensa.nl

Prosensa Holding B.V. Logo

More from Press Releases

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

21st Century Fox Scoops Up Local News Stations

21st Century Fox Scoops Up Local News Stations

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Three-Part FREE Webinar Series

Three-Part FREE Webinar Series

March 24 Full-Day Course Offering: Professional Approach to Trading SPX

March 24 Full-Day Course Offering: Professional Approach to Trading SPX